HODL - New Portfolio
D S
HODLIndividual Investor
Ranked #60,837 out of 858,896 TipRanks' Investors
Success Rate
32 out of 61
profitable transactions
profitable transactions
Average Return
104.41%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▼ 6.58%
6-Month Return▼ 7.57%
12-Month Return▲ 53.45%
YTD Return▼ 15.94%
Total Return▲ 190.28%
Best Trade
Bio
Performance
19.47%0-19.47%
▲ 12.88%
▲ 3.56%
▲ 19.47%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 9.30%
Oct 2025
▼ 3.68%
▲ 0.19%
▼ 7.37%
Nov 2025
▼ 0.10%
▲ 0.08%
▲ 3.73%
Dec 2025
▲ 4.06%
▲ 1.47%
▼ 1.18%
Jan 2026
▼ 1.12%
▼ 0.86%
▼ 9.26%
Feb 2026
▲ 0.60%
▼ 4.94%
▼ 3.52%
Mar 2026
▲ 4.89%
▲ 4.48%
▼ 2.83%
Apr 2026
▲ 12.88%▲ 3.56%▲ 19.47%
▲ 10.96%▲ 2.38%▲ 9.30%
▼ 3.68%▲ 0.19%▼ 7.37%
▼ 0.10%▲ 0.08%▲ 3.73%
▲ 4.06%▲ 1.47%▼ 1.18%
▼ 1.12%▼ 0.86%▼ 9.26%
▲ 0.60%▼ 4.94%▼ 3.52%
▲ 4.89%▲ 4.48%▼ 2.83%
Recent Activity
Tesla
66.97%
▲ 20.86%
11
Buy
Jul 21, 2025
Nvidia
17.77%
▲ 429.41%
11
Buy
Jul 21, 2025
Xtract One
0.35%
▲ 7.89%
3
Buy
Jul 21, 2025
Lemonade
4.26%
▲ 35.51%
3
Buy
Jul 21, 2025
SoFi
―
▲ 12.98%
7
Close
Jan 05, 2025
Editas Medicine
―
▼ 72.21%
4
Close
Dec 12, 2024
Organigram Global
―
▼ 17.32%
2
Close
Dec 12, 2024
Delivra Health Brands
―
▼ 73.47%
2
Close
Nov 17, 2024
Auxly Cannabis Group
―
▼ 85.11%
2
Close
Nov 17, 2024
Aurora Cannabis
―
▼ 93.29%
2
Close
Nov 17, 2024
Shift Technologies
―
▼ 99.94%
2
Close
Jul 21, 2024
Palantir Technologies
10.22%
▲ 609.77%
7
Buy
Jul 21, 2024
Hyliion Holdings
―
▼ 68.31%
2
Close
Jul 21, 2024
Opendoor Technologies
―
▼ 87.79%
2
Close
Jul 21, 2024
Crispr Therapeutics AG
―
▼ 32.22%
2
Close
Jul 21, 2024
Arcturus Therapeutics
―
▼ 36.81%
2
Close
Jul 21, 2024
Atea ASA
―
▼ 4.61%
2
Close
Jul 21, 2024
Proterra
―
▼ 99.90%
2
Close
Mar 14, 2024
Vestas Wind Systems AS
―
▼ 14.30%
2
Close
Mar 19, 2022
ReNew Energy Global
―
▼ 11.27%
2
Close
Mar 19, 2022